Emcure Pharmaceuticals Limited (NSE:EMCURE)

Emcure Pharmaceuticals Revenue

Emcure Pharmaceuticals had revenue of 28.20B INR in the quarter ending September 30, 2026, with 24.26% growth. This brings the company's total for the last twelve months to 102.34B, up 21.12% year-over-year. In the fiscal year ending March 31, 2026, Emcure Pharmaceuticals had annual revenue of 92.04B with 16.56% growth. That makes Emcure Pharmaceuticals the 7,257th largest company in the world by revenue and 279th in India.

• Revenue (ttm): 102.34B
• Revenue Growth: +21.12%
• P/S Ratio: 4.28
• Revenue / Employee: 14.80M
• Employees: 6,914
• Market Cap: 442.79B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• India 40.27B 43.8%
• Europe 18.50B 20.1%
• ROW 18.40B 20.0%
• North America 14.87B 16.2%

Fiscal year ended Mar 31, 2026 See the full Emcure Pharmaceuticals breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	92.04B	13.08B	16.56%
Mar 31, 2025	78.96B	12.38B	18.59%
Mar 31, 2024	66.58B	6.72B	11.23%
Mar 31, 2023	59.86B	1.30B	2.23%
Mar 31, 2022	58.55B	8.22B	16.33%

Data Source: S&P Global Market Intelligence Last updated: Nov 3, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 9, 2026

Data Sources Report a data error